You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Guidelines on Management of Dyspnea (Breathlessness) in Patients with Cancer

ID: ES SMG-3 Jan 2019
Type of Content: Guidelines & Advice, Evidence Summary
Document Status: Current
Authors:
Glenn G. Fletcher

Guideline Objective

The current evidence summary was developed to assist the Patient Reported Outcomes and Symptom Management Program of CCO in revising the algorithm on dyspnea prepared in 2010.

Patient Population

The target population is adult patients with cancer experiencing dyspnea. Acute symptoms induced by the current cancer treatment (chemotherapy, radiotherapy) were considered outside the scope.

Intended Guideline Users

The intended users of this evidence summary are staff of the Patient Reported Outcomes and Symptom Management Program. This evidence summary may also be of interest to physicians, nurses, caregivers, and patients dealing with cancer or palliative care symptom management.

Research Questions

N/A

pdf download Full Report (PDF) (727.31 KB)